| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
double homeobox 4 | 0.604 | 0.500 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2014 | |||||||||
|
N-acetylneuraminate synthase | 0.545 | 0.692 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2006 | |||||||||
|
POU class 5 homeobox 1 pseudogene 3 | 0.452 | 0.808 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2019 | |||||||||
|
POU class 5 homeobox 1 pseudogene 4 | 0.452 | 0.808 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2019 | |||||||||
|
SSX family member 2 | 0.581 | 0.615 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2006 | |||||||||
|
transient erythroblastopenia of childhood | 0.659 | 0.577 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | |||||||||
|
salt inducible kinase 1B (putative) | 0.653 | 0.385 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | |||||||||
|
cancer/testis antigen 1B | 0.507 | 0.731 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
cancer/testis antigen 1A | 0.508 | 0.731 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
immunoglobulin heavy variable 1-12 (pseudogene) | 0.569 | 0.654 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | |||||||||
|
MAGE family member A4 | 0.653 | 0.346 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
suppression of anchorage independence 1 | 0.560 | 0.615 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | |||||||||
|
SSX family member 2B | 0.599 | 0.577 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
ROS proto-oncogene 1, receptor tyrosine kinase | 0.439 | 0.885 | 1.6E-72 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
mucin 4, cell surface associated | 0.506 | 0.769 | 2.8E-54 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2011 | 2019 | ||||||||
|
SSX family member 1 | 0.674 | 0.308 | 3.7E-45 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
ubiquitin specific peptidase 6 | 0.633 | 0.692 | 2.9E-35 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
desmocollin 3 | 0.570 | 0.808 | 2.3E-21 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
solute carrier family 12 member 9 | 0.454 | 0.769 | 1.2E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
retinoid isomerohydrolase RPE65 | 0.417 | 0.808 | 6.5E-14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
GLI family zinc finger 1 | 0.431 | 0.846 | 7.7E-14 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2020 | ||||||||
|
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites | 0.805 | 0.154 | 1.3E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ASPSCR1 tether for SLC2A4, UBX domain containing | 0.653 | 0.538 | 4.4E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 |